Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Newborns With Retinopathy of Prematurity
NCT01079715Phase 3Completed
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Jan 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol in retinopathy of prematurity (ROP), sponsored by Meyer Children's Hospital IRCCS. Started Jan 2010; status: completed.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT01079715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01079715.